RxDoctor Payments Data

Christopher Vaughan, MD

Pain Medicine · Boise, IDNPI 1366822926

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (43.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Medtronic at 46.7% of the total. Reporting peaked in 2019 at $13,433 and has fallen 65.7% since, to $4,607 in 2025. Among pain medicine clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,867in general payments, 2019–2025

Across 362 payments — averaging $71.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$12K
  • Boston Scientific$4K
  • Abbott$3K
  • Spinefrontier, Inc.$2K
  • Stryker$1K
  • Relievant Medsystems, Inc.$728
  • plus $3K from 21 others

What the payments were for

  • Grants$11,25043%
  • Travel & lodging$6,02123%
  • Food & beverage$8,59633%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,867 in reported general payments places this provider in the 90th percentile of 32 pain medicine providers in Idaho.

See all pain medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$185,997
Medicare patients
266
Services billed
1,491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl24$13,178
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen354$9,701
Buprenorphine35$7,315
Pregabalin162$5,632
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen144$3,794
Oxycodone Hcl149$3,490
Celecoxib35$2,852
Gabapentin161$2,385
Morphine Sulfate ErMorphine Sulfate55$1,689
Buprenorphine Hcl21$1,134
Morphine Sulfate22$924
Cefadroxil104$757
Tizanidine Hcl42$655
Hydromorphone Hcl18$615
Baclofen43$528

Paid to pharmacies, not to this prescriber.

Other pain medicine in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →